Bioequivalence implies therapeutic equivalence. II. Economic and social approach
November 17, 2014
 |
|
|||
| Article Title: | Bioequivalence implies therapeutic equivalence. II. Economic and social approach | |||
| Authors: | Gherghiceanu F., Mircioiu C., Lupuleasa D., Mircioiu I., Iordache M., Toderescu C.D., Sandulovici R. | |||
| Affiliation: | 1 ”Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, Dept of Biopharmacy Bucharest, Romania 3 2 “Titu Maiorescu “ University, Faculty of Pharmacy, Dept of Biopharmacy, Bucharest, Romania ”Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, Dept of Biophysics, Bucharest, Romania | |||
| Abstract: | ABSTRACT: In spite of the fact that bioequivalent drugs are therapeutically equivalent, following a lot of apparent scientific disputes which traduce in fact the contradictions between different groups of interest, the sharing of the market between brand and generic drugs differs from country to country, which implies finally great differences in expenses and efficiency of health systems. Generic drugs account for 88% of all prescriptions filled USA and only 23 % in Romania. Authors consider that this situation decreases the availability for assurence of fundamental wright to health for poor people and propose two solutions for entering of Romania on the right. First is the modification of the curricula at universities of medicine and pharmacy by including biopharmacy and pharmacokinetics, GMP, GCP and QAS essential information. Second proposal is the renaissance of the public cotrol of drugs starting from the model of Institute for State Control and Research of Drugs based on the facilities and specialists of the faculties of pharmacy and National Institute for Chemico-Pharmaceutical Research and Development. Such an institution could convince medical doctors and patients that really Romanian generics drugs have the same quality as brand drugs. | |||
| Keywords: | health politics, generic drugs, bioequivalence, therapeutic equivalence, public drug control | |||
| *Correspondence: | Correspondence: Ion Mircioiu, “Titu Maiorescu“ University, Faculty of Pharmacy, Dept of Biopharmacy, Calea Vacaresti, 187, 040051, Bucharest, Romania, tel 0040722147004, e-mail: ionutu@yahoo.com |
About The Author
